25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Lotus Pharmaceuticals Inc
Buy, Hold or Sell?

Let's analyze Lotus Pharmaceuticals Inc together

I guess you are interested in Lotus Pharmaceuticals Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Lotus Pharmaceuticals Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Lotus Pharmaceuticals Inc

I send you an email if I find something interesting about Lotus Pharmaceuticals Inc.

1. Quick Overview

1.1. Quick analysis of Lotus Pharmaceuticals Inc (30 sec.)










1.2. What can you expect buying and holding a share of Lotus Pharmaceuticals Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$0.00
Expected worth in 1 year
$0.00
How sure are you?
0.0%

+ What do you gain per year?

Total Gains per Share
$0.00
Return On Investment
-0.2%

For what price can you sell your share?

Current Price per Share
$0.00
Expected price per share
$0.0006 - $0.0034
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Lotus Pharmaceuticals Inc (5 min.)




Live pricePrice per Share (EOD)
$0.00
Intrinsic Value Per Share
$0.00 - $0.00
Total Value Per Share
$0.00 - $0.00

2.2. Growth of Lotus Pharmaceuticals Inc (5 min.)




Is Lotus Pharmaceuticals Inc growing?

Current yearPrevious yearGrowGrow %
How rich?-$119.2k-$93.5k-$20k-17.6%

How much money is Lotus Pharmaceuticals Inc making?

Current yearPrevious yearGrowGrow %
Making money-$4k-$4.6k542.7513.3%
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

2.3. Financial Health of Lotus Pharmaceuticals Inc (5 min.)




2.4. Comparing to competitors in the Shell Companies industry (5 min.)




  Industry Rankings (Shell Companies)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Lotus Pharmaceuticals Inc?

Welcome investor! Lotus Pharmaceuticals Inc's management wants to use your money to grow the business. In return you get a share of Lotus Pharmaceuticals Inc.

First you should know what it really means to hold a share of Lotus Pharmaceuticals Inc. And how you can make/lose money.

Speculation

The Price per Share of Lotus Pharmaceuticals Inc is $0.0033. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Lotus Pharmaceuticals Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Lotus Pharmaceuticals Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.00. Based on the TTM, the Book Value Change Per Share is $0.00 per quarter. Based on the YOY, the Book Value Change Per Share is $0.00 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Lotus Pharmaceuticals Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps0.000.0%0.000.0%0.00-0.1%0.00-0.1%0.00-0.1%
Usd Book Value Change Per Share0.000.0%0.000.0%0.00-0.1%0.00-112.0%0.00-112.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.000.0%0.000.0%0.00-0.1%0.00-112.0%0.00-112.0%
Usd Price Per Share0.00-0.00-0.01-0.01-0.01-
Price to Earnings Ratio-1,050.86--856.93--2,095.24--1,313.48--1,313.48-
Price-to-Total Gains Ratio-4,203.45--3,427.71--4,347.79--3,228.08--3,228.08-
Price to Book Ratio-88.13--117.76--267.88--252.02--252.02-
Price-to-Total Gains Ratio-4,203.45--3,427.71--4,347.79--3,228.08--3,228.08-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.0033
Number of shares303030
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.00
Gains per Quarter (303030 shares)-0.46-1,119.82
Gains per Year (303030 shares)-1.83-4,479.27
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-2-120-4479-4489
20-4-140-8959-8968
30-5-160-13438-13447
40-7-180-17917-17926
50-9-200-22396-22405
60-11-220-26876-26884
70-13-240-31355-31363
80-15-260-35834-35842
90-16-280-40313-40321
100-18-300-44793-44800

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.010.00.00.0%0.010.00.00.0%0.010.00.00.0%21.014.00.060.0%
Book Value Change Per Share0.04.00.00.0%0.010.00.00.0%0.010.00.00.0%0.010.00.00.0%20.015.00.057.1%
Dividend per Share0.00.04.00.0%0.00.010.00.0%0.00.010.00.0%0.00.010.00.0%0.00.035.00.0%
Total Gains per Share0.04.00.00.0%0.010.00.00.0%0.010.00.00.0%0.010.00.00.0%20.015.00.057.1%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Lotus Pharmaceuticals Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.0000.000+63%0.000+148%-0.004+398193%-0.004+398193%
Book Value Per Share--0.0000.000-5%0.000-22%0.000-19%0.000-19%
Current Ratio--0.0340.032+8%0.017+97%0.031+9%0.031+9%
Debt To Asset Ratio--29.39635.985-18%78.222-62%53.778-45%53.778-45%
Debt To Equity Ratio----0%-0%-0%-0%
Dividend Per Share----0%-0%-0%-0%
Eps--0.0000.000+63%0.000+85%0.000+171%0.000+171%
Free Cash Flow Per Share--0.0000.000+7%0.000+40%0.000+83%0.000+83%
Free Cash Flow To Equity Per Share--0.0000.000-2000%0.000-78%0.000+40%0.000+40%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--0.000--------
Intrinsic Value_10Y_min--0.000--------
Intrinsic Value_1Y_max--0.000--------
Intrinsic Value_1Y_min--0.000--------
Intrinsic Value_3Y_max--0.000--------
Intrinsic Value_3Y_min--0.000--------
Intrinsic Value_5Y_max--0.000--------
Intrinsic Value_5Y_min--0.000--------
Market Cap8891916.211-18%10508628.25013270511.315-21%24587495.584-57%22123501.601-53%22123501.601-53%
Net Profit Margin----0%-0%-0%-0%
Operating Margin----0%-0%-0%-0%
Operating Ratio----0%-0%-0%-0%
Pb Ratio-74.575+15%-88.134-117.759+34%-267.880+204%-252.024+186%-252.024+186%
Pe Ratio-889.192+15%-1050.863-856.927-18%-2095.244+99%-1313.484+25%-1313.484+25%
Price Per Share0.003-18%0.0040.005-21%0.009-57%0.008-51%0.008-51%
Price To Free Cash Flow Ratio-577.847+15%-682.911-914.547+34%-1587.657+132%-1147.130+68%-1147.130+68%
Price To Total Gains Ratio-3556.766+15%-4203.451-3427.707-18%-4347.789+3%-3228.079-23%-3228.079-23%
Quick Ratio--0.0030.008-56%0.009-61%0.018-81%0.018-81%
Return On Assets---0.595-1.333+124%-3.868+550%-2.939+394%-2.939+394%
Return On Equity----0%-0%-0%-0%
Total Gains Per Share--0.0000.000+63%0.000+148%-0.004+398193%-0.004+398193%
Usd Book Value---119234.000-113587.500-5%-93542.000-22%-97835.400-18%-97835.400-18%
Usd Book Value Change Per Share--0.0000.000+63%0.000+148%-0.004+398193%-0.004+398193%
Usd Book Value Per Share--0.0000.000-5%0.000-22%0.000-19%0.000-19%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps--0.0000.000+63%0.000+85%0.000+171%0.000+171%
Usd Free Cash Flow---3847.000-4099.750+7%-5394.750+40%-7308.800+90%-7308.800+90%
Usd Free Cash Flow Per Share--0.0000.000+7%0.000+40%0.000+83%0.000+83%
Usd Free Cash Flow To Equity Per Share--0.0000.000-2000%0.000-78%0.000+40%0.000+40%
Usd Market Cap8891916.211-18%10508628.25013270511.315-21%24587495.584-57%22123501.601-53%22123501.601-53%
Usd Price Per Share0.003-18%0.0040.005-21%0.009-57%0.008-51%0.008-51%
Usd Profit---2500.000-4069.750+63%-4612.500+85%-7053.900+182%-7053.900+182%
Usd Revenue----0%-0%-0%-0%
Usd Total Gains Per Share--0.0000.000+63%0.000+148%-0.004+398193%-0.004+398193%
 EOD+2 -6MRQTTM+15 -12YOY+15 -125Y+16 -1110Y+16 -11

3.3 Fundamental Score

Let's check the fundamental score of Lotus Pharmaceuticals Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-889.192
Price to Book Ratio (EOD)Between0-1-74.575
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.003
Current Ratio (MRQ)Greater than10.034
Debt to Asset Ratio (MRQ)Less than129.396
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-0.595
Total1/10 (10.0%)

3.4 Technical Score

Let's check the technical score of Lotus Pharmaceuticals Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5048.688
Ma 20Greater thanMa 500.003
Ma 50Greater thanMa 1000.003
Ma 100Greater thanMa 2000.003
OpenGreater thanClose0.003
Total1/5 (20.0%)

4. In-depth Analysis

4.1 About Lotus Pharmaceuticals Inc

Lotus Pharmaceuticals, Inc. does not have significant operations. Previously, it was engaged in the development, manufacture, and sale of pharmaceuticals in the People's Republic of China. The company is based in Nashville, Tennessee.

Fundamental data was last updated by Penke on 2024-11-04 20:37:04.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Lotus Pharmaceuticals Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Lotus Pharmaceuticals Inc to the Shell Companies industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Lotus Pharmaceuticals Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Shell Companies)
PeriodCompanyIndustry (mean)+/- 
MRQ--48.1%+48.1%
TTM--6.2%+6.2%
YOY--8.8%+8.8%
5Y--8.0%+8.0%
10Y--17.8%+17.8%
4.3.1.2. Return on Assets

Shows how efficient Lotus Pharmaceuticals Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Lotus Pharmaceuticals Inc to the Shell Companies industry mean.
  • -59.5% Return on Assets means that Lotus Pharmaceuticals Inc generated $-0.60 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Lotus Pharmaceuticals Inc:

  • The MRQ is -59.5%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -133.3%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-59.5%TTM-133.3%+73.8%
TTM-133.3%YOY-386.8%+253.5%
TTM-133.3%5Y-293.9%+160.6%
5Y-293.9%10Y-293.9%0.0%
Compared to industry (Shell Companies)
PeriodCompanyIndustry (mean)+/- 
MRQ-59.5%-1.0%-58.5%
TTM-133.3%-0.7%-132.6%
YOY-386.8%0.2%-387.0%
5Y-293.9%-1.9%-292.0%
10Y-293.9%-1.9%-292.0%
4.3.1.3. Return on Equity

Shows how efficient Lotus Pharmaceuticals Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Lotus Pharmaceuticals Inc to the Shell Companies industry mean.
  • 0.0% Return on Equity means Lotus Pharmaceuticals Inc generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Lotus Pharmaceuticals Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Shell Companies)
PeriodCompanyIndustry (mean)+/- 
MRQ--0.9%+0.9%
TTM--0.3%+0.3%
YOY-0.6%-0.6%
5Y--1.3%+1.3%
10Y--1.7%+1.7%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Lotus Pharmaceuticals Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Lotus Pharmaceuticals Inc is operating .

  • Measures how much profit Lotus Pharmaceuticals Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Lotus Pharmaceuticals Inc to the Shell Companies industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Lotus Pharmaceuticals Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Shell Companies)
PeriodCompanyIndustry (mean)+/- 
MRQ--137.7%+137.7%
TTM--27.8%+27.8%
YOY--20.4%+20.4%
5Y--12.9%+12.9%
10Y--29.0%+29.0%
4.3.2.2. Operating Ratio

Measures how efficient Lotus Pharmaceuticals Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Shell Companies industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Lotus Pharmaceuticals Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
Compared to industry (Shell Companies)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.361-1.361
TTM-0.807-0.807
YOY-0.930-0.930
5Y-0.465-0.465
10Y-0.673-0.673
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Lotus Pharmaceuticals Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Lotus Pharmaceuticals Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Shell Companies industry mean).
  • A Current Ratio of 0.03 means the company has $0.03 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Lotus Pharmaceuticals Inc:

  • The MRQ is 0.034. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.032. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.034TTM0.032+0.002
TTM0.032YOY0.017+0.014
TTM0.0325Y0.031+0.000
5Y0.03110Y0.0310.000
Compared to industry (Shell Companies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0340.056-0.022
TTM0.0320.106-0.074
YOY0.0170.763-0.746
5Y0.0311.519-1.488
10Y0.0311.585-1.554
4.4.3.2. Quick Ratio

Measures if Lotus Pharmaceuticals Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Lotus Pharmaceuticals Inc to the Shell Companies industry mean.
  • A Quick Ratio of 0.00 means the company can pay off $0.00 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Lotus Pharmaceuticals Inc:

  • The MRQ is 0.003. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.008. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.003TTM0.008-0.004
TTM0.008YOY0.009-0.001
TTM0.0085Y0.018-0.010
5Y0.01810Y0.0180.000
Compared to industry (Shell Companies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0030.155-0.152
TTM0.0080.555-0.547
YOY0.0090.664-0.655
5Y0.0183.541-3.523
10Y0.0183.385-3.367
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Lotus Pharmaceuticals Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Lotus Pharmaceuticals Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Lotus Pharmaceuticals Inc to Shell Companies industry mean.
  • A Debt to Asset Ratio of 29.40 means that Lotus Pharmaceuticals Inc assets are financed with 2,939.6% credit (debt) and the remaining percentage (100% - 2,939.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Lotus Pharmaceuticals Inc:

  • The MRQ is 29.396. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 35.985. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ29.396TTM35.985-6.589
TTM35.985YOY78.222-42.237
TTM35.9855Y53.778-17.793
5Y53.77810Y53.7780.000
Compared to industry (Shell Companies)
PeriodCompanyIndustry (mean)+/- 
MRQ29.3960.454+28.942
TTM35.9850.313+35.672
YOY78.2220.102+78.120
5Y53.7780.352+53.426
10Y53.7780.353+53.425
4.5.4.2. Debt to Equity Ratio

Measures if Lotus Pharmaceuticals Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Lotus Pharmaceuticals Inc to the Shell Companies industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Lotus Pharmaceuticals Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
Compared to industry (Shell Companies)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.417-0.417
TTM-0.298-0.298
YOY-0.086-0.086
5Y-1.200-1.200
10Y-1.176-1.176
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Lotus Pharmaceuticals Inc generates.

  • Above 15 is considered overpriced but always compare Lotus Pharmaceuticals Inc to the Shell Companies industry mean.
  • A PE ratio of -1,050.86 means the investor is paying $-1,050.86 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Lotus Pharmaceuticals Inc:

  • The EOD is -889.192. Based on the earnings, the company is expensive. -2
  • The MRQ is -1,050.863. Based on the earnings, the company is expensive. -2
  • The TTM is -856.927. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-889.192MRQ-1,050.863+161.671
MRQ-1,050.863TTM-856.927-193.936
TTM-856.927YOY-2,095.244+1,238.317
TTM-856.9275Y-1,313.484+456.558
5Y-1,313.48410Y-1,313.4840.000
Compared to industry (Shell Companies)
PeriodCompanyIndustry (mean)+/- 
EOD-889.192-9.576-879.616
MRQ-1,050.863-12.597-1,038.266
TTM-856.927-6.612-850.315
YOY-2,095.2446.714-2,101.958
5Y-1,313.484-20.883-1,292.601
10Y-1,313.484-18.407-1,295.077
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Lotus Pharmaceuticals Inc:

  • The EOD is -577.847. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -682.911. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -914.547. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-577.847MRQ-682.911+105.063
MRQ-682.911TTM-914.547+231.637
TTM-914.547YOY-1,587.657+673.110
TTM-914.5475Y-1,147.130+232.582
5Y-1,147.13010Y-1,147.1300.000
Compared to industry (Shell Companies)
PeriodCompanyIndustry (mean)+/- 
EOD-577.847-43.888-533.959
MRQ-682.911-51.054-631.857
TTM-914.547-69.344-845.203
YOY-1,587.657-180.471-1,407.186
5Y-1,147.130-152.346-994.784
10Y-1,147.130-145.862-1,001.268
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Lotus Pharmaceuticals Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Shell Companies industry mean).
  • A PB ratio of -88.13 means the investor is paying $-88.13 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Lotus Pharmaceuticals Inc:

  • The EOD is -74.575. Based on the equity, the company is expensive. -2
  • The MRQ is -88.134. Based on the equity, the company is expensive. -2
  • The TTM is -117.759. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-74.575MRQ-88.134+13.559
MRQ-88.134TTM-117.759+29.624
TTM-117.759YOY-267.880+150.122
TTM-117.7595Y-252.024+134.266
5Y-252.02410Y-252.0240.000
Compared to industry (Shell Companies)
PeriodCompanyIndustry (mean)+/- 
EOD-74.5752.670-77.245
MRQ-88.1342.726-90.860
TTM-117.7592.574-120.333
YOY-267.8801.404-269.284
5Y-252.0241.625-253.649
10Y-252.0241.618-253.642
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-06-30. All numbers in thousands.

Summary
Total Assets4
Total Liabilities123
Total Stockholder Equity-119
 As reported
Total Liabilities 123
Total Stockholder Equity+ -119
Total Assets = 4

Assets

Total Assets4
Total Current Assets4
Long-term Assets0
Total Current Assets
Cash And Cash Equivalents 0
Other Current Assets 4
Total Current Assets  (as reported)4
Total Current Assets  (calculated)4
+/-0
Long-term Assets
Long-term Assets  (as reported)0
Long-term Assets  (calculated)0
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities123
Long-term Liabilities0
Total Stockholder Equity-119
Total Current Liabilities
Short-term Debt 123
Total Current Liabilities  (as reported)123
Total Current Liabilities  (calculated)123
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Common Stock2,695
Retained Earnings -32,802
Other Stockholders Equity 29,988
Total Stockholder Equity (as reported)-119
Total Stockholder Equity (calculated)-119
+/-0
Other
Cash and Short Term Investments 0
Common Stock Shares Outstanding 2,694,516
Liabilities and Stockholders Equity 4
Net Debt 123
Net Working Capital -119
Short Long Term Debt Total 123



6.2. Balance Sheets Structured

All numbers in thousands.

 Trend2024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-30
> Total Assets 
109
96
85
83
75
22,478
20,601
24,398
27,953
30,221
36,900
43,385
49,016
54,786
63,709
64,238
72,367
80,840
84,381
88,357
96,525
103,833
103,185
107,753
114,494
120,157
21
29
35
8
1
1
1
1
1
4
2
6
3
4
43624111118352921120,157114,494107,753103,185103,83396,52588,35784,38180,84072,36764,23863,70954,78649,01643,38536,90030,22127,95324,39820,60122,47875838596109
   > Total Current Assets 
89
77
68
67
60
14,106
12,752
16,475
20,303
22,859
29,438
35,003
31,958
25,802
13,763
7,538
7,067
7,615
7,695
7,204
8,970
5,071
4,541
5,283
7,199
7,557
2
0
0
8
1
1
1
1
1
4
2
6
3
4
436241111180027,5577,1995,2834,5415,0718,9707,2047,6957,6157,0677,53813,76325,80231,95835,00329,43822,85920,30316,47512,75214,1066067687789
       Cash And Cash Equivalents 
5
3
1
2
1
1,253
2,089
4,456
8,441
6,194
4,558
3,589
3,401
2,657
1,279
1,229
1,830
2,561
3,946
1,125
1,079
898
1,340
1,311
886
159
2
0
0
8
1
1
1
1
1
0
0
2
1
0
012001111180021598861,3111,3408981,0791,1253,9462,5611,8301,2291,2792,6573,4013,5894,5586,1948,4414,4562,0891,25312135
       Net Receivables 
0
2
2
0
0
3,076
7,277
7,134
9,581
15,674
20,431
24,169
20,787
13,882
8,177
1,411
2,150
1,782
1,800
1,686
5,061
1,950
1,973
1,336
4,878
6,001
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000006,0014,8781,3361,9731,9505,0611,6861,8001,7822,1501,4118,17713,88220,78724,16920,43115,6749,5817,1347,2773,07600220
       Inventory 
73
70
66
65
59
9,777
3,134
4,329
1,994
852
3,411
6,783
7,087
8,622
3,788
3,726
2,775
2,995
1,040
3,301
1,685
1,197
635
1,323
895
1,269
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000001,2698951,3236351,1971,6853,3011,0402,9952,7753,7263,7888,6227,0876,7833,4118521,9944,3293,1349,7775965667073
   > Long-term Assets 
20
19
17
16
15
8,372
7,849
7,923
7,650
7,362
7,461
8,382
17,058
28,984
49,946
56,700
65,301
73,226
76,686
81,153
87,555
98,762
98,643
102,470
107,294
112,600
19
29
35
0
0
0
0
0
0
0
0
0
0
0
00000000000352919112,600107,294102,47098,64398,76287,55581,15376,68673,22665,30156,70049,94628,98417,0588,3827,4617,3627,6507,9237,8498,3721516171920
       Property Plant Equipment 
17
16
15
14
13
5,842
5,814
6,150
6,133
6,115
6,170
6,312
6,551
7,680
7,555
9,592
14,770
22,872
16,224
21,310
28,105
38,985
39,338
43,092
47,248
52,281
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000052,28147,24843,09239,33838,98528,10521,31016,22422,87214,7709,5927,5557,6806,5516,3126,1706,1156,1336,1505,8145,8421314151617
       Intangible Assets 
0
0
0
0
0
237
208
188
173
154
1,291
1,308
1,298
1,266
39,407
47,108
47,608
50,353
59,103
58,674
49,218
49,583
59,305
59,379
60,046
7,170
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000007,17060,04659,37959,30549,58349,21858,67459,10350,35347,60847,10839,4071,2661,2981,3081,29115417318820823700000
       Long-term Assets Other 
4
4
2
2
2
2,293
1,827
1,584
1,344
1,093
0
763
9,209
20,038
2,984
0
2,922
0
1,360
1,169
10,232
10,194
0
0
0
53,149
19
29
35
0
0
0
0
0
0
0
0
0
0
0
0000000000035291953,14900010,19410,2321,1691,36002,92202,98420,0389,20976301,0931,3441,5841,8272,29322244
> Total Liabilities 
50
55
81
101
155
10,643
8,836
10,609
10,865
10,038
10,263
11,510
13,976
16,405
18,574
15,225
18,297
21,065
18,583
15,072
13,777
12,939
14,162
13,822
17,245
20,703
43
51
57
76
78
83
84
93
97
107
109
117
120
123
12312011710910797938483787657514320,70317,24513,82214,16212,93913,77715,07218,58321,06518,29715,22518,57416,40513,97611,51010,26310,03810,86510,6098,83610,643155101815550
   > Total Current Liabilities 
50
55
81
101
155
2,487
4,106
6,536
6,874
7,105
4,786
2,754
4,972
7,133
9,340
9,702
12,839
15,667
12,648
9,143
7,830
6,900
8,051
7,610
10,868
14,201
43
51
57
76
78
83
84
93
97
107
109
117
120
123
12312011710910797938483787657514314,20110,8687,6108,0516,9007,8309,14312,64815,66712,8399,7029,3407,1334,9722,7544,7867,1056,8746,5364,1062,487155101815550
       Short-term Debt 
38
42
66
73
89
0
0
1,988
2,382
2,375
2,562
0
0
0
0
1,994
4,159
6,751
3,132
2,482
0
0
5,987
6,025
6,124
6,183
43
51
57
76
78
82
84
93
97
107
109
117
120
123
1231201171091079793848278765751436,1836,1246,0255,987002,4823,1326,7514,1591,99400002,5622,3752,3821,988008973664238
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,987
6,025
6,124
6,183
0
0
0
0
0
0
0
0
0
0
109
0
0
0
00010900000000006,1836,1246,0255,9870000000000000000000000
       Accounts payable 
12
13
6
11
50
1,124
705
745
797
625
764
638
1,028
1,845
2,170
2,572
3,465
3,751
4,181
3,388
3,444
3,672
38
32
20
2
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0000000010000022032383,6723,4443,3884,1813,7513,4652,5722,1701,8451,0286387646257977457051,124501161312
       Other Current Liabilities 
0
0
9
16
16
1,091
2,974
3,115
3,124
3,538
930
1,340
3,303
4,658
6,605
4,341
4,503
4,534
4,171
2,477
3,739
1,884
7,508
7,033
10,314
13,668
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000013,66810,3147,0337,5081,8843,7392,4774,1714,5344,5034,3416,6054,6583,3031,3409303,5383,1243,1152,9741,0911616900
   > Long-term Liabilities 
0
0
0
0
0
8,155
4,730
4,073
3,991
2,933
5,477
8,756
9,004
9,272
9,234
5,523
5,458
5,398
5,935
5,930
5,947
6,039
6,111
6,211
6,376
6,502
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000006,5026,3766,2116,1116,0395,9475,9305,9355,3985,4585,5239,2349,2729,0048,7565,4772,9333,9914,0734,7308,15500000
       Other Liabilities 
0
0
0
0
0
0
863
814
767
718
738
769
655
656
526
460
394
329
866
860
857
864
869
936
1,015
1,088
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000001,0881,015936869864857860866329394460526656655769738718767814863000000
> Total Stockholder Equity
59
41
4
-18
-80
11,836
11,765
13,788
17,088
20,183
26,637
31,876
35,040
38,381
45,134
49,013
54,070
59,776
65,798
73,285
82,748
90,894
89,023
93,932
97,249
99,454
-22
-22
-22
-68
-76
-82
-83
-92
-96
-103
-107
-111
-117
-119
-119-117-111-107-103-96-92-83-82-76-68-22-22-2299,45497,24993,93289,02390,89482,74873,28565,79859,77654,07049,01345,13438,38135,04031,87626,63720,18317,08813,78811,76511,836-80-1844159
   Common Stock
6
6
6
6
7
41
41
41
41
42
42
42
42
42
42
43
44
44
47
51
53
53
27
28
28
28
2,945
2,945
2,945
2,945
2,945
2,695
2,695
2,695
2,695
2,695
2,695
2,695
2,695
2,695
2,6952,6952,6952,6952,6952,6952,6952,6952,6952,9452,9452,9452,9452,94528282827535351474444434242424242424141414176666
   Retained Earnings 
-178
-196
-305
-327
-418
5,458
5,258
6,052
9,050
11,224
14,356
15,195
16,081
19,883
25,558
28,709
32,958
37,756
45,740
50,669
50,751
57,451
53,925
56,149
64,160
59,170
-22
-22
-22
-32,751
-32,759
-32,765
-32,766
-32,774
-32,779
-32,786
-32,790
-32,794
-32,799
-32,802
-32,802-32,799-32,794-32,790-32,786-32,779-32,774-32,766-32,765-32,759-32,751-22-22-2259,17064,16056,14953,92557,45150,75150,66945,74037,75632,95828,70925,55819,88316,08115,19514,35611,2249,0506,0525,2585,458-418-327-305-196-178
   Capital Surplus 0000000000000000000000000000000000000000
   Treasury Stock0000000000000000000000000000000000000000
   Other Stockholders Equity 
231
231
303
303
331
5,965
5,965
7,072
7,128
7,866
8,096
10,884
11,277
11,277
11,554
15,970
16,774
17,616
15,649
18,192
27,247
27,267
27,919
30,026
23,786
30,050
-2,945
-2,945
-2,945
29,738
29,738
29,988
29,988
32,682
32,682
32,682
29,988
29,988
29,988
29,988
29,98829,98829,98829,98832,68232,68232,68229,98829,98829,73829,738-2,945-2,945-2,94530,05023,78630,02627,91927,26727,24718,19215,64917,61616,77415,97011,55411,27711,27710,8848,0967,8667,1287,0725,9655,965331303303231231



6.3. Balance Sheets

All numbers in thousands.




6.4. Cash Flows

All numbers in thousands.




6.5. Income Statements

All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2023-12-31. All numbers in thousands.

Gross Profit (+$)
totalRevenue0
Cost of Revenue-0
Gross Profit00
 
Operating Income (+$)
Gross Profit0
Operating Expense-19
Operating Income-19-19
 
Operating Expense (+$)
Research Development0
Selling General Administrative0
Selling And Marketing Expenses0
Operating Expense190
 
Net Interest Income (+$)
Interest Income0
Interest Expense-0
Other Finance Cost-0
Net Interest Income0
 
Pretax Income (+$)
Operating Income-19
Net Interest Income0
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-19-19
EBIT - interestExpense = -187
-187
-19
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-187-19
Earnings Before Interest and Taxes (EBITDA)-19
 
After tax Income (+$)
Income Before Tax-19
Tax Provision-0
Net Income From Continuing Ops0-19
Net Income-19
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses19
Total Other Income/Expenses Net00
 

Technical Analysis of Lotus Pharmaceuticals Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Lotus Pharmaceuticals Inc. The general trend of Lotus Pharmaceuticals Inc is BEARISH with 28.6% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Lotus Pharmaceuticals Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-28.6%) Bearish trend (28.6%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Lotus Pharmaceuticals Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.0034 < 0.0034 < 0.0034.

The bearish price targets are: 0.0008 > 0.0006 > 0.0006.

Tweet this
Lotus Pharmaceuticals Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Lotus Pharmaceuticals Inc. The current mas is .

The long score for the Moving Averages is 5/14.
The longshort score for the Moving Averages is -4/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Lotus Pharmaceuticals Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Lotus Pharmaceuticals Inc. The current macd is 0.000052.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Lotus Pharmaceuticals Inc price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Lotus Pharmaceuticals Inc. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Lotus Pharmaceuticals Inc price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Lotus Pharmaceuticals Inc Daily Moving Average Convergence/Divergence (MACD) ChartLotus Pharmaceuticals Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Lotus Pharmaceuticals Inc. The current adx is 14.54.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Lotus Pharmaceuticals Inc shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Lotus Pharmaceuticals Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Lotus Pharmaceuticals Inc. The current sar is 0.00162861.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Lotus Pharmaceuticals Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Lotus Pharmaceuticals Inc. The current rsi is 48.69. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Lotus Pharmaceuticals Inc Daily Relative Strength Index (RSI) ChartLotus Pharmaceuticals Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Lotus Pharmaceuticals Inc. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Lotus Pharmaceuticals Inc price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Lotus Pharmaceuticals Inc Daily Stochastic Oscillator ChartLotus Pharmaceuticals Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Lotus Pharmaceuticals Inc. The current cci is 12.72.

Lotus Pharmaceuticals Inc Daily Commodity Channel Index (CCI) ChartLotus Pharmaceuticals Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Lotus Pharmaceuticals Inc. The current cmo is -7.39062921.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Lotus Pharmaceuticals Inc Daily Chande Momentum Oscillator (CMO) ChartLotus Pharmaceuticals Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Lotus Pharmaceuticals Inc. The current willr is -100.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Lotus Pharmaceuticals Inc Daily Williams %R ChartLotus Pharmaceuticals Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Lotus Pharmaceuticals Inc.

Lotus Pharmaceuticals Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Lotus Pharmaceuticals Inc. The current atr is 0.00019833.

Lotus Pharmaceuticals Inc Daily Average True Range (ATR) ChartLotus Pharmaceuticals Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Lotus Pharmaceuticals Inc. The current obv is 225,548.

Lotus Pharmaceuticals Inc Daily On-Balance Volume (OBV) ChartLotus Pharmaceuticals Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Lotus Pharmaceuticals Inc. The current mfi is 53.43.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Lotus Pharmaceuticals Inc Daily Money Flow Index (MFI) ChartLotus Pharmaceuticals Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Lotus Pharmaceuticals Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-07-05WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-08STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-09STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-11SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-22MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-07-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-24MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-07-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-31SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-20MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-08-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-08-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-28ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-05DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-09-09MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-23MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-25MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-09-26SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-09-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-10WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-10-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-16MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-10-24MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-25SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-29SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-10-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-31MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-11-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-11ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-15WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-11-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-11-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-21MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).

6.3. Candlestick Patterns

Lotus Pharmaceuticals Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Lotus Pharmaceuticals Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5048.688
Ma 20Greater thanMa 500.003
Ma 50Greater thanMa 1000.003
Ma 100Greater thanMa 2000.003
OpenGreater thanClose0.003
Total1/5 (20.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Lotus Pharmaceuticals Inc with someone you think should read this too:
  • Are you bullish or bearish on Lotus Pharmaceuticals Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Lotus Pharmaceuticals Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Lotus Pharmaceuticals Inc

I send you an email if I find something interesting about Lotus Pharmaceuticals Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Lotus Pharmaceuticals Inc.

Receive notifications about Lotus Pharmaceuticals Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.